About Us

Pioneers in precision genomics

Foresight Diagnostics was founded by four Stanford University physicians and scientists who sought to develop high-performing circulating tumor DNA (ctDNA) assays by improving the limits of detection through innovative techniques and enhanced bioinformatics. Our first product, Foresight CLARITY™, utilizes a proprietary and patented phased variant (PV) detection method to improve the accuracy of ctDNA tests and minimal residual disease (MRD) measurement.

Since our founding in 2020…

Authored 30+ scientific publications and presentations
background image
Raised $86M from institution VC’s
background image
Partnered with 25+ biopharma and academic researchers
background image
Established an automated and scalable CLIA-registered lab in Boulder, Colorado

Our Investors

Civilization Ventures - Logo
Bluebird - Logo
Pear - Logo
Agent Capital - Logo
Stanford University - Logo
University of Colorado - logo

Leadership

Jake Chabon, PhD
Chief Executive Officer, Chief Scientific Officer, Founder
David Kurtz, MD, PhD
Chief Medical Officer, Head of Research, Founder
Sandra Close, PhD
Chief Operations Officer, Chief Compliance Officer
John Truesdell
Chief Business Officer
Ruben Gutierrez
General Counsel
Aaron Berlin
Senior Vice President, Development and Engineering
Brittin Davis
Senior Vice President, Business and Laboratory Operations and Strategy
Mary Stewart
Senior Vice President, Compliance, Public Policy, and Communications
Sara Head
Vice President, Marketing
JP Younis
Vice President, Information Technology and Security
Pete Reid
Vice President, Human Resources

Board of Directors

Chief Executive Officer, Chief Scientific Officer, Founder
Scientific Advisor, Founder, Board Member
Board Member
Board Member
Board Observer

Scientific Advisory Board

Scientific Advisor, Founder, Board Member
Scientific Advisory Board Member
Scientific Advisory Board Member
Business Advisor